Browse All
Displaying 1 - 5 of 6
Author:Dy-Hollins, Marisela Chibnik, Lori Osiecki, Lisa Sharma, Nutan Mathews, Carol Scharf, Jeremiah
Session Name:S42: Movement Disorders: Genetics and Risk Modifiers
Topic:Movement Disorders
Program Number:S42.009
Author Institution:Massachusetts General Hospital, Boston, MA University of Florida, Gainesville, FL
Author:Paganoni, Sabrina Berry, James Quintana, Melanie Macklin, Eric Saville, Benjamin Andrews, Jinsy Shefner, Jeremy Fournier, Christina Babu, Suma Maragakis, Nicholas Oskarsson, Bjorn Detry, Michelle Chase, Marianne Sherman, Alex Yu, Hong Pothier, Lindsay Drake, Kristin Chibnik, Lori Bind, Marie-Abele Vestrucci, Matteo McGlothlin, Anna Marion, Joseph Duda, Petra Harvey, Brittany Qureshi, Irfan Donohue, Mary Granit, Volkan Grossman, Katheryn Glanzman, Robert Hotchkin, Michael Goldberg, Y Paul Leitner, Melanie Hayden, Michael Cudkowicz, Merit
Session Name:PL5: Clinical Trials Plenary Session
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Program Number:PL5.004
Author Institution:Massachusetts General Hospital, Boston, MA Berry Consultants, Austin, TX MGH Biostatistics Center, Boston, MA Columbia University Medical Center, New York, NY Barrow Neurological Institute, Phoenix, AZ Emory University, Atlanta, GA Johns Hopkins University School of Medicine, Baltimore, MD Mayo Clinic, Jacksonville, FL Harvard School of Public Health, Boston, MA UCB, Brussels, Belgium Biohaven Pharmaceuticals, New Haven, CT Biohaven Pharmaceuticals, Inc., New Haven, CT Biohaven Pharmaceuticals, East Petersburg, PA Clene Nanomedicine Inc, Holladay, UT Clene Nanomedicine, Inc., Salt Lake City, UT Prilenia Therapeutics, Herzliya, Israel Accelerating Neuroventures, Boston, MA
Author:Jordan, Justin Merker, Vanessa Chibnik, Lori Ma, Yidan Ullrich, Nicole Yohay, Kaleb Knight, Pamela Radtke, Heather Plotkin, Scott
Session Name:P3: Practice, Policy and Ethics: Improving Patient Care & Research 1
Topic:Practice, Policy, and Ethics
Program Number:P3.002
Author Institution:Massachusetts General Hospital, Boston, MA Harvard School of Public Health, Boston, MA Boston Children's Hospital, Boston, MA NYU Langone Medical Center, New York, NY Children's Tumor Foundation, New York, NY Children's Tumor Foundation Medical College of Wisconsin, New York, NY
Author:Kelly, Hannah Vishnevetsky, Anastasia Chibnik, Lori Levy, Michael
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.012
Author Institution:School of Medicine, Case Western Reserve University, Cleveland, OH, USA, Cleveland, OH
Author:Berry, James Maragakis, Nicholas Paganoni, Sabrina Quintana, Melanie Macklin, Eric Saville, Benjamin Andrews, Jinsy Shefner, Jeremy Detry, Michelle Menon, Parvathi Huynh, William Mahoney, Colin Stommel, Elijah Hall, Meghan Connolly, Mariah Kittle, Gale Chase, Marianne Sherman, Alexander Yu, Hong Pothier, Lindsay Drake, Kristin Chibnik, Lori Bind, Marie-Abele Vestrucci, Matteo Glanzman, Robert Hotchkin, Michael Vucic, Steve Kiernan, Matthew Cudkowicz, Merit Study Group, HEALEY ALS Platform Trial Investigators, RESCUE-ALS
Session Name:P8: Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1
Program Number:P8.004
Author Institution:Massachusetts General Hospital, Boston, MA Johns Hopkins University School of Medicine, Baltimore, MD Berry Consultants, San Francisco, CA MGH Biostatistics Center, Boston, MA Columbia University Medical Center, New York, NY Barrow Neurological Institute, Phoenix, AZ Westmead Public Hospital, Sydney, Australia Prince of Wales Hospital, Randwick, Australia University of Sydney, Sydney, Australia Dartmouth-Hitchock Med Ctr/Dept of Neuro, Lebanon, NH Massachusetts General Hospital, Charlestown, MA Clene Nanomedicine Inc, Holladay, UT Clene Nanomedicine, Inc., Salt Lake City, UT Brain and Mind Centre, Sydney, Australia HEALEY ALS Platform Trial, Boston, MA RESCUE-ALS Trial, Sydney, Australia
